Drawing for MORFFI

USPTO serial 87222158

MORFFI

Reviewed by CopyMark Law Group

Reg. 5578007Status 710
Filing date
Status date
Registration date
Oct 9, 2018
Examiner
SOBRAL, CHRISTINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MORFFI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole M. Meyer

NICOLE M. MEYER DICKINSON WRIGHT PLLC1825 EYE STREET, N.W., SUITE 900WASHINGTON, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products in the nature of chemicals for use in industry and science; chemicals and chemical reagents for non-medical laboratory use; chemicals, reagents, immunoassay preparations and substances for testing blood, bodily fluids samples, antibodies and purified agents for diagnostic purposes; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; reagents in kit form for performing assays for scientific and research use; chemical substances and immunoassays in the nature of assays for use in diagnostic kits for research purposes; diagnostic reagents for scientific and research use; exogenous antigen, endogenous antigen and autoantigen agents for activating cellular functions; proteins for scientific and research use; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; cell culture proteins for scientific and research use; monoclonal antibodies for in vitro scientific and research use; antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; enzymes for in vitro, scientific, and research use; transferrin, namely, glycoproteins; albumin for scientific and research purposes; human antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; human and animal plasma for scientific and medical research use; human and animal serum, namely, albumin and bovine serum for scientific and medical research use; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; chemicals and chemical reagents for diagnostic laboratory useSECTION 8 - CANCELLED—
005Chemicals and chemical reagents for medical use; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical and medical diagnostic purposes; reagents in kit form for performing assays for diagnostic and medical purposes; diagnostic reagents for diagnostic and medical use; proteins for diagnostic and medical use; cell culture proteins for diagnostic and medical use; monoclonal antibodies for diagnostic and medical use; enzymes for diagnostic and medical use; albumin for diagnostic and medical use; human and animal blood plasma; chemicals agents for use in separation for diagnostic and medical use; cell culture media for use in separation techniques for diagnostic and medical useSECTION 8 - CANCELLED—
040Custom manufacturing services of goods relating to conjugate blocking technology; custom manufacturing services of goods relating to assays and lateral flow assays and enhancement and performance of lateral flow assaysSECTION 8 - CANCELLED—
042Scientific and technological development services and research and design relating thereto in the field of lateral flow immunoassays and conjugate blocking technology; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; scientific and technological services, namely, design and research relating to lateral flow conjugation processes; scientific and technological services, namely, design and research relating to the enhancement and performance of lateral flow assays; industrial analysis and research services for the enhancement and performance of lateral flow assays; diagnostic and medical laboratory services; chemical analysis and research for others; diagnostic medical testing for medical, scientific and research purposes; diagnostic medical testing relating to assays for diagnostic, medical and research purposes; diagnostic medical testing relating to conjugate blocking technology for diagnostic, medical, scientific and technological purposes; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for the diagnostics industry; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; research and analysis for the diagnostics industry; technological services, namely, reading of results, processing of results, technical information, data sheets, and brochures relating to assays and lateral flow assays; technological and scientific research services relating to assays and lateral flow assays; lateral flow development of assays and lateral flow diagnostic testing services for medical, scientific and research purposes; development of lateral flow assays, lateral flow immunoassays and research into conjugate blocking technology; advisory, information and consultancy services relating to all of the aforesaidSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2025C8..CANCELLED SEC. 8 (6-YR)—
Oct 9, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2018DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Aug 30, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 17, 2018IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 17, 2018D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 13, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 24, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 24, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 24, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 1, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 28, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 24, 2017ALIEASSIGNED TO LIE—
Aug 4, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2017DOCKASSIGNED TO EXAMINER—
Nov 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance